STIM1-associated genes) in different cell types, including malignant cells in the tumor and non-malignant cells from the tumor microenvironment; 2) characterize the functional impact of SCGs in specific cell types; and 3) determine the prognostic value of SCGs derived from different cell types. This evidence concerns the gene STIM1 and neoplasm.